Exhibit 99.1
COMPANY CONTACT:
Rhonda F. Rhyne,
President
rrhyne@cardiodynamics.com
800-778-4825 Ext. 1013
CardioDynamics Ranked in Deloitte's Technology
Fast 50 Program for San Diego
Company Also Announces CEO Interview with WallSt.net
SAN DIEGO, CA--October 16, 2007--CardioDynamics (Nasdaq: CDIC), the innovator
and leader of Impedance Cardiography (ICG) technology, has been named to
Deloitte's prestigious Technology Fast 50 Program for San Diego, a ranking of
the 50 fastest growing technology, media, telecommunications, and life sciences
companies in the area by Deloitte & Touche USA LLP, one of the nation's leading
professional services organizations. Rankings are based on the percentage
revenue growth over five years from 2002-2006.
CardioDynamics' Chief Executive Officer, Michael K. Perry, stated, "This is the
ninth year we have been given the honor of being ranked in the Fast 50. This is
a great achievement considering the number and quality of technology and life
sciences companies in San Diego. We are proud of the proven benefits of our
proprietary ICG technology, the tenacity and dedication to customer service of
our direct sales and clinical sales force and our entire company's focus towards
improving drug management for cardiac medicine."
CardioDynamics' increase in revenues of 29% percent from 2002 to 2006 resulted
in a 50th ranking in the Technology Fast 50 for San Diego. To qualify for the
Technology Fast 50, companies must have had operating revenues of at least
$50,000 in 2002 and $5,000,000 in 2006, be headquartered in North America, and
be a company that owns proprietary technology or proprietary intellectual
property that contributes to a significant portion of the company's operating
revenues; or devotes a significant proportion of revenues to the research and
development of technology.
The Company also announced Mr. Perry will be featured in an exclusive interview
with www.wallst.net on October 17, 2007, at 10:00 a.m. PT (1:00 p.m., ET). The
interview will be posted on www.wallst.net by 8 p.m. ET on October 17. The
interview will cover topics including CardioDynamics' market potential, growth
initiatives, competitive advantage, recent news, and milestones for investors to
watch for.
To hear the interview in its entirety, visit http://www.wallst.net, and click on
"Interviews." The interview can be accessed either by locating the company's
ticker symbol under the appropriate exchange on the left-hand column of the
"Interviews" section of the site, or by entering the company's ticker symbol in
the Search Archive window once it is posted.
About CardioDynamics
CardioDynamics (Nasdaq: CDIC), the ICG Company, is the innovator and leader of
an important medical technology called impedance cardiography (ICG). The Company
develops, manufactures and markets noninvasive ICG products. The Company's ICG
Systems are being used by physicians around the world to help battle the number
one killer of men and women--cardiovascular disease. Partners include GE
Healthcare and Philips Medical Systems. For additional information, please refer
to the company's Web site at www.cdic.com.
About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its
member firms and their respective subsidiaries and affiliates. As a Swiss Verein
(association), neither Deloitte Touche Tohmatsu nor any of its member firms has
any liability for each other's acts or omissions. Each of the member firms is a
separate and independent legal entity operating under the names "Deloitte",
"Deloitte & Touche", "Deloitte Touche Tohmatsu" or other related names. Services
are provided by the member firms or their subsidiaries or affiliates and not by
the Deloitte Touche Tohmatsu Verein.
Deloitte & Touche USA LLP is the US member firm of Deloitte Touche Tohmatsu. In
the US, services are provided by the subsidiaries of Deloitte & Touche USA LLP
(Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory
Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte &
Touche USA LLP.
About WallSt.net
www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned
subsidiary of Financial Media Group, Inc.
(http://www.financialmediagroupinc.com). The Web site is a leading provider of
timely business news, executive interviews, multimedia content, and research
tools. Financial Media Group, Inc. also owns http://www.mywallst.net, a
financial social network for investors, and Financial Filings Corp.
(http://www.financialfilings.com), a provider of media and compliance solutions
to publicly traded companies. In addition to WallSt.net, WallStreet Direct, Inc.
owns and operates WallStRadio (http://www.wallstradio.com), a business and
finance podcast Web site. We are expecting to receive two hundred eighty dollars
from Advanced Wound Technologies, for the dissemination of this press release.
For a complete list of our advertisers, and advertising relationships, visit
www.wallst.net/disclaimer/disclaimer.asp.
Forward-Looking (Safe Harbor) Statement
Except for historical and factual information contained herein, this press
release may contain forward-looking statements, the accuracy of which are
necessarily subject to uncertainties and risks including the Company's primary
dependence on the BioZ product line, and various uncertainties characteristic of
early growth companies, as well as other risks detailed in the Company's filings
with the SEC, including its 2006 Form 10-K. The Company does not undertake to
update the disclosures contained in this press release.
SOURCE CardioDynamics
-0- 10/16/2007
/CONTACT: Rhonda F. Rhyne, President of CardioDynamics,
1-800-778-4825, Ext. 1013, rrhyne@cardiodynamics.com/